Histone Modifying Enzymes in Gynaecological Cancers

Area of Science:

• Oncology
• Genetics
• Epigenetics

Background:

• Epigenetic dysregulation, including DNA methylation and histone modifications, is prevalent in gynecological cancers.
• Histones critically influence chromosomal structure and gene expression, with their modifications being distinct from DNA methylation's silencing role.
• Histone modifying enzymes, crucial for chromatin dynamics, are less understood but represent potential therapeutic targets.

Purpose of the Study:

• To review the role of epigenetics in gynecological cancers.
• To explore the potential of epigenetic modifications as therapeutic targets.
• To highlight the exploitation of epigenetic mechanisms for cancer treatment.

Main Methods:

• Literature review of epigenetic mechanisms in gynecological cancers.
• Analysis of histone modifications and DNA methylation patterns.
• Discussion of epigenetic inhibitors and their therapeutic potential.

Main Results:

• Epigenetic dysregulation is a common feature across gynecological malignancies.
• Altered DNA methylation and histone modifications impact gene expression and genome stability.
• Biomarkers indicate patient sensitivity to epigenetic inhibitors.

Conclusions:

• Epigenetic mechanisms play a significant role in the development and progression of gynecological cancers.
• Epigenetic inhibitors offer a promising therapeutic strategy, particularly for complex tumors.
• Targeting epigenetic pathways presents a viable approach for gynecological cancer treatment.